Literature DB >> 28795850

Selection and characterization of antibody clones are critical for accurate flow cytometry-based monitoring of CD123 in acute myeloid leukemia.

Nicole M Cruz1, Mayumi Sugita1, Nathan Ewing-Crystal1, Linda Lam1, Roman Galetto2, Agnes Gouble2, Julianne Smith3, Duane C Hassane1, Gail J Roboz1, Monica L Guzman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28795850      PMCID： PMC5809236          DOI： 10.1080/10428194.2017.1361023

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  4 in total

1.  The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells.

Authors:  C T Jordan; D Upchurch; S J Szilvassy; M L Guzman; D S Howard; A L Pettigrew; T Meyerrose; R Rossi; B Grimes; D A Rizzieri; S M Luger; G L Phillips
Journal:  Leukemia       Date:  2000-10       Impact factor: 11.528

Review 2.  Acute Myeloid Leukemia.

Authors:  Hartmut Döhner; Daniel J Weisdorf; Clara D Bloomfield
Journal:  N Engl J Med       Date:  2015-09-17       Impact factor: 91.245

Review 3.  Targeting acute myeloid leukemia stem cells: a review and principles for the development of clinical trials.

Authors:  Daniel A Pollyea; Jonathan A Gutman; Lia Gore; Clayton A Smith; Craig T Jordan
Journal:  Haematologica       Date:  2014-08       Impact factor: 9.941

Review 4.  T cells expressing CD123 chimeric antigen receptors for treatment of acute myeloid leukemia.

Authors:  Armen Mardiros; Stephen J Forman; Lihua E Budde
Journal:  Curr Opin Hematol       Date:  2015-11       Impact factor: 3.284
  4 in total
  3 in total

1.  Immune-Based Therapeutic Interventions for Acute Myeloid Leukemia.

Authors:  Fabiana Perna; Manuel R Espinoza-Gutarra; Giuseppe Bombaci; Sherif S Farag; Jennifer E Schwartz
Journal:  Cancer Treat Res       Date:  2022

2.  Allogeneic TCRαβ deficient CAR T-cells targeting CD123 in acute myeloid leukemia.

Authors:  Mayumi Sugita; Roman Galetto; Hongliang Zong; Nathan Ewing-Crystal; Vicenta Trujillo-Alonso; Nuria Mencia-Trinchant; Winnie Yip; Stephanie Filipe; Celine Lebuhotel; Agnès Gouble; Duane C Hassane; Julianne Smith; Gail J Roboz; Monica L Guzman
Journal:  Nat Commun       Date:  2022-04-28       Impact factor: 17.694

3.  Approval of tagraxofusp-erzs for blastic plasmacytoid dendritic cell neoplasm.

Authors:  Naveen Pemmaraju; Marina Konopleva
Journal:  Blood Adv       Date:  2020-08-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.